Biography:
Susumu Hama, Ph.D., is an Assistant Professor at the Faculty of Pharmaceutical Sciences, Musashino University, Japan. He earned his Ph.D. from Hokkaido University. His research focuses on developing pathological environment-responsive nanoparticles for cancer therapy. He notably pioneered strategies to overcome the "PEG dilemma" using pH-responsive, charge-inverting peptides. Currently, Dr. Hama is advancing the design of multifunctional lipid-based carriers modified with novel devices to achieve both prolonged systemic circulation and efficient intracellular delivery. His work aims to bridge the gap between fundamental pharmaceutical science and clinical oncology.
